Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Progyny Inc has a consensus price target of $24.4 based on the ratings of 13 analysts. The high is $43 issued by Keybanc on February 28, 2024. The low is $17 issued by Barclays on November 14, 2024. The 3 most-recent analyst ratings were released by JP Morgan, JP Morgan, and Barclays on January 28, 2025, December 2, 2024, and November 14, 2024, respectively. With an average price target of $19 between JP Morgan, JP Morgan, and Barclays, there's an implied -19.49% downside for Progyny Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Progyny (NASDAQ:PGNY) was reported by JP Morgan on January 28, 2025. The analyst firm set a price target for $23.00 expecting PGNY to fall to within 12 months (a possible -2.54% downside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for Progyny (NASDAQ:PGNY) was provided by JP Morgan, and Progyny maintained their neutral rating.
There is no last upgrade for Progyny
The last downgrade for Progyny Inc happened on December 2, 2024 when JP Morgan changed their price target from $22 to $17 for Progyny Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Progyny, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Progyny was filed on January 28, 2025 so you should expect the next rating to be made available sometime around January 28, 2026.
While ratings are subjective and will change, the latest Progyny (PGNY) rating was a maintained with a price target of $17.00 to $23.00. The current price Progyny (PGNY) is trading at is $23.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.